1. Introduction {#sec1}
===============

Cochlear implant (CI) is one of the most significant treatments to help restore auditory function in patients with severe to profound sensorineural hearing loss. It has become a relatively safe procedure via the well-standardized transmastoid approach. One of the previously established contraindications for cochlea implant is chronic middle ear inflammation due to concerns of increased risk of intracranial infection and/or device extrusion ([@bib11], [@bib1]). Recently there is mounting new evidence indicating that cochlear implants can be safely performed in patients with chronic otitis media or atelectasis ([@bib6], [@bib14], [@bib9]). Otitis media with effusion (OME), also called serous otitis media, is a very common childhood disease. The reported incidence is as high as 20% among children, with a peak around ages one to two years ([@bib9], [@bib10], [@bib3]). Cochlear implants in pediatric patients, especially those younger than 2 years of age, have become increasingly common. Clinicians are often confronted with OME in the expanding population of cochlear implant candidates. Accordingly, this study aims to report our experiences with cochlear implantation in children with OME.

2. Material and methods {#sec2}
=======================

A retrospective review of 24children (ages 11 months to 5.2 years)who underwent cochlear implantation in an ear with active OME was conducted between January 2011 to November 2014 in the Department of Otorhinolaryngology and Head and Neck Surgery, PLA Hospital, China. Study protocol was approved by the hospital\'s Institutional Review Board. All the 24 subjects were under 6 years of age without any residual hearing when admitted to our department as cochlear implant candidates. The candidates received a comprehensive preoperative radiological evaluation. Their radiologic findings showed middle ear and mastoid opacification with intact ossicles, indicating the presence of OME. Otoscopy found no evidence of tympanic membrane perforation. After audiological assessment, the 24 candidates were all diagnosed with bilateral profound sensorineural hearing loss without any residue hearing. All the operations were performed by the same experienced surgical team in our department. The demographic data, etiology of deafness, and surgical techniques were retrieved from medical records and summarized in [Table 1](#tbl1){ref-type="table"}.Table 1Demographic and clinical details of the 24 children.CaseGenderAge at implantationCause of deafnessGroupImplanted sideCochlear device1Male1 year 7 monthsCHL1Left24Contour2Female2 years 8 monthsLVAS1RightSonata3Female2 years 8 monthsLVAS1RightC40+4Male2 years 4 monthsCHL1RightC40+5Male1 year 9 monthsCHL1RightC40+6Male3 years 5 monthsCHL1RightC40+7Male1 year 7 monthsCHL1RightSonata8Male1 year 5 monthsLVAS1Right24Contour9Male1 year 3 monthsCHL1RightFreedom10Female2 years 6 monthsLVAS&MM1Right24K11Female2 years 5 monthsCHL1LeftFreedom12Female2 years 1 monthsMM1Right24Contour13Male4 years 5 monthsCHL1RightSonata14Female11 monthsCHL1RightSonata15Female2 years 7 monthsLVAS1Left24Contour16Male1 year 4 monthsCHL1RightConcerto17Male1 year 7 monthsLVAS2Right24Contour18Male1 year 8 monthsCHL2RightHiRes 90K19Female3 years 10 monthsCHL2RightFreedom20Male4 years 10 monthsLVAS2LeftFreedom21Male2 years 7 monthsCHL2RightFreedom22Female5 years 2 monthsLVAS2LeftFreedom23Male1 year 7 monthsMM2LeftSonata24Female2 years 1 monthsCHL2LeftFreedom[^2]

Based on how the incus was handled, the subjects were divided into Group1 (incus left in place, n = 16) and Group 2 (incus removed, n = 8).

At follow ups, complications, and auditory and speech rehabilitation outcomes were reviewed. Complications included wound infection, meningitis or other intracranial infections, cerebrospinal fluid otorrhea, post-implant perforation of tympanic membrane, device extrusion and recurrence of OME. To assess post-implant auditory function and speech recognition, a prospective questionnaire was constructed including questions from Categories of Auditory Performance (CAP) ([@bib4]), Speech Intelligibility Rating (SIR) ([@bib2]) and the Meaningful Auditory Integration Scale (MAIS or infant toddler-MAIS) ([@bib12]). The composite questionnaires were administered through interviews with the parents by an audiologist. All the subjects reported daily use of the CI and attending speech therapy programs.

3. Surgical techniques {#sec3}
======================

Based on preoperative imaging and intraoperative finding, all subjects were determined to have active OME in the implant ear at the time of CI operation. To pursue an early hearing and speech rehabilitation, all the children in our study received one-stage cochlear implant operations (one patient had an adenoidectomy procedure done 3 months before CI).

All cochlear implantations in this study were performed via the facial recess approach with round window insertion under general anesthesia. Following a retroauricular incision, approximately 3 cm in length, an intact canal wall mastoidectomy and transantrum posterior tympanotomy were completed. The mastoid antrum was enlarged for full visualization of the short process of the incus. The facial recess was identified and enlarged to approach the round window niche. Intraoperatively, edematous mucosa with effusion was noticed in the middle ear, confirming active serous otitis media. The middle ear and mastoid cavity were drained and irrigated with dexamethasone (1 mL of 5 mg/mL dexamethasone in normal saline solution, Shandong Xinhua Pharmaceutical Company Limited) and epinephrine (0.3 mL of 1 mg/mL, 1:10,000, Beijing YOKON).

For casesin Group 2, the incudostapedial joint was separated and the incus removed, followed by expansion of the mastoid antrum by drilling the posterior bony buttress between the facial recess and fossa incudis for insertion of the electrode array in a straight line through the round window membrane.

In all cases, an anchoring well was drilled in the cranium for placement of the internal receiver-stimulator. The overhang of round window niche was removed using a diamond burr (0.5--1 mm) form maximum exposure of the round window membrane. Cochleostomy was finished anteroinferiorly from the round window membrane into the basal turn of the cochlea. The electrode array was inserted carefully into the scala tympani following the curvature of the cochlea and the cochleostomy was sealed by small pieces of temporalis fascia. The retroauricular incision was closed in layered sutures. Absorbable sutures and mastoid dressing was applied in all cases.

4. Statistical analysis {#sec4}
=======================

Statistical analysis was performed with the SPSS16.0 software. Pre- and post-implant CAP and SIR scores were compared with self-paired T-test, following usual conditions of application. Significance was set at P \< 0.05.

5. Results {#sec5}
==========

After the receiver-stimulator was placed, intraoperative neural response telemetry (NRT) responded well in all 24 children, which confirmed appropriate placement of the electrode array in the cochlea. Five days after implantation, an X-ray in Stenvers projection was performed in all cases, which also confirmed appropriate positions of the electrode array.

The average follow up was 27 months, ranging from 10 months to 3 years 9 months, during which time none of the subjects experienced any immediate or delayed complications. No recurrence of OME was detected in both groups after the CI surgery.

The questionnaire surveys, composed of questions from CAP, SIR and MAIS (or IT-MAIS) are shown in [Table 2](#tbl2){ref-type="table"}.Table 2CI characteristics and auditory speech performance scores of the 24 children.CaseAge at follow-upLength of deafness (month)Length of CI use (month)CAPSIRMAIS[a](#tbl2fna){ref-type="table-fn"}PrePostPrePost*Group1: Facial Recess Approach Implantation*15 years 5 months194407153725 years 9 months323516143535 years 6 months323316143445 years 2 months283306143454 years 7 months213305143366 years 3 months413305143774 years 4 months192205133383 years 1 months171904133093 years 9 months1529051333104 years 11 months3028051435114 years 9 months2927051435124 years 2 months2524051330136 years 5 months5323151337142 years 7 months1119041430154 years 1 months3117151331162 years 2 months169031228*Group2: Facial Recess Approach Implantation with Incus Removal*174 years 2 months1930151434184 years 2 months2029051433196 years 2 months4627061436207 years 2 months242526538214 years 11 months3126051436227 years 4 months202547538233 years 6 months1922051333243 years 10 months2520051332[^3]

[Table 3](#tbl3){ref-type="table"} lists the age at implantation, age at follow up, length of deafness, length of CI use, pre-and post-implant auditory and speech performance scores.Table 3Mean, standard deviation (S.D.) and median of characteristics of CI use and pre- and post-implant scores of MAIS or IT-MAIS, CAP and SIR.ItemsMean ± S.D.MedianAge at Implantation (month)29.12 ± 13.7926.50Age at Follow-up (month)57.08 ± 16.0256.00Length of Deafness (month)25.96 ± 10.0724.50Length of CI Use (month)26.75 ± 7.2227.00MAIS or IT-MAIS[a](#tbl3fna){ref-type="table-fn"}33.88 ± 2.7938.00CAP Pre-implant0.46 ± 0.930.00 Post-implant5.21 ± 0.885.00SIR Pre-implant1.17 ± 0.571.00 Post-implant3.71 ± 0.754.00[^4]

The preoperative and postoperative CAP scores were 0.46 ± 0.93 and 5.21 ± 0.88, respectively. The preoperative and postoperative SIR scores were 1.17 ± 0.57 and 3.71 ± 0.75, respectively. For both CAP and SIR in both Groups1 and 2, postoperative scores were higher than preoperative scores (t = −25.95 and −14.09, respectively, p \< 0.01) ([Fig. 1](#fig1){ref-type="fig"}). Given the difference in the number of cases between Group 1 and Group 2, scores of MAIS or IT-MAIS, CAP and SIR were not compared between the two groups.Fig. 1The comparison between preimplant and postimplant of the mean scores for CAP and SIR.

6. Discussion {#sec6}
=============

Middle ear infection can spread via a cochlear implant electrode into the labyrinth and even intracranial space to cause post-operative infection, meningitis or fatal intracranial complications ([@bib8], [@bib16], [@bib7], [@bib5], [@bib15]). The presence of chronic and recurrent inflammation in mastoid and middle ear cavities is considered a risk factor for cochlear implant electrode impairment and/or extrusion ([@bib7], [@bib5]). Additionally, effusion and bleeding from inflamed middle ear mucosa can obscure the operative field and challenge even the most experienced surgeons intraoperatively ([@bib16], [@bib7], [@bib5], [@bib15], [@bib17]). Based on these considerations, the current recommendation for cochlear implant candidates is to treat chronic otitis media with effusion before CI surgery.

The standard treatment of OME includes use of intranasal corticosteroids for a limited time and myringotomy with or without insertion of ventilating tubes ([@bib11], [@bib3]). Treatment of underlying eustachian tube dysfunction, including adenoidectomy and tonsillectomy, are often required in persistent or recurrent cases ([@bib3], [@bib18]). With improvement of surgical techniques, one stage cochlear implantation has become feasible in patients with OME, albeit with a higher rate of complications ([@bib6]).

With the goal to improve surgical techniques and to reduce complications for CI patients with active OME, we developed a new technique that involved incus removal after opening the facial recess, via the classical posterior tympanotomy and facial recess approach. We hypothesized that removing incus would contribute to enlargement of tympanic volume, thus improving ventilation of the middle ear. [@bib9] reported that performing mastoidectomy during cochlear implantation had no influence on natural history of otitis media with effusion. The reason may be that aeration and gas composition of the middle ear depend to a great extent on the function of mastoid and middle ear mucosa ([@bib13]). With incus removal in conjunction with mastoidectomy, the volume of tympanic cavity will be enlarged further without excessive impairment of middle ear mucosa.

During postoperative follow-up in our study, all electrodes were activated successfully without any immediate or delayed complications. Furthermore, all the implanted devices functioned normally and all 24 children achieved improved auditory performance and speech intelligibility.

7. Conclusions {#sec7}
==============

In our study, one-stage operation via the facial recess approach with round window insertion proved to be safe and effective in cochlear implant candidates with active OME. No immediate or delayed complications were encountered in our patients with or without incus removal. Postoperative follow-up findings showed improvement of auditory function and speech intelligibility in all 24 children. Based on this study, we propose incus removal in cochlear implant candidates with OME via the classic facial recess approach with round window insertion to avoid staged procedures and gain early rehabilitation of audition and speech.
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[^3]: Use the IT-MAIS questionnaire if the subject is under 3-year old.

[^4]: Use the IT-MAIS questionnaire if the subject is under 3-year old.
